Evaluation of functional integrity of the retinohypothalamic tract in advanced glaucoma using multifocal electroretinography and light-induced melatonin suppression

Experimental Eye Research

Volumn 91, Issue 5, 2010, Pages 578-583

  Pérez Rico, Consuelo ^a   de la Villa, Pedro ^b   Arribas Gómez, Ignacio ^a   Blanco, Román ^b  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Glaucoma; Melanopsin; Melatonin; Retinal ganglion cells; Retinohypothalamic tract

Indexed keywords

MELANOPSIN; MELATONIN; SCOTOPSIN;

ADULT; AGED; ARTICLE; CELL SURVIVAL; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FEMALE; HUMAN; LIGHT EXPOSURE; MALE; NEUROENDOCRINE SYSTEM; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PINEAL BODY; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOIMMUNOASSAY; RETINA GANGLION CELL; RETINA NERVE CELL; VISION; VISUAL ACUITY; CASE CONTROL STUDY; LIGHT; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERIMETRY; PHYSIOLOGY; PROSPECTIVE STUDY; RADIATION EXPOSURE; SALIVA; SUPRACHIASMATIC NUCLEUS; VISUAL FIELD;

AGED; CASE-CONTROL STUDIES; CELL SURVIVAL; ELECTRORETINOGRAPHY; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; LIGHT; MALE; MELATONIN; MIDDLE AGED; OPTIC NERVE DISEASES; PERIMETRY; PINEAL GLAND; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; RETINAL GANGLION CELLS; ROD OPSINS; SALIVA; SUPRACHIASMATIC NUCLEUS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELDS;

EID: 78049514143     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.07.012     Document Type: Article

References (43)

1. Berson D.M. Strange vision: ganglion cells as circadian photoreceptors. Trends Neurosci. 2003, 26:314-320.
2. Berson D.M., Dunn F.A., Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002, 295:1070-1073.
3. Blumenthal E.Z., Weinreb R.N. Assessment of the retinal nerve fiber layer in clinical trials of glaucoma neuroprotection. Surv. Ophthalmol. 2001, 45(Suppl. 3):S305-S312.
4. Cooper, H.M., Drouyer, E., Dkhissi-Benyahhya, O., Gronfier, C., Chiquet, C., WoldeMussie, E., Guadalupe, R., Wheler, L.A., Denis, P. ARVO 2008 Annual Meeting. Effects of glaucoma on the circadian timing system in mice and men. Abstract, 182/A327.
5. Czeisler C.A., Shanahan T.L., Klerman E.B., Martens H., Brotman D.J., Emens J.S., Klein T., Rizzo J.F. Suppression of melatonin secretion in some blind patients by exposure to bright light. N. Engl. J. Med. 1995, 332:6-11.
6. Drouyer E., Dkhissi-Benyahya O., Chiquet C., WoldeMussie E., Ruiz G., Wheeler L.A., Denis P., Cooper H.M. Glaucoma alters the circadian timing system. PLoS ONE 2008, 3:e3931.
7. Foster R.G., Bellingham J. Inner retinal photoreceptors (IRPs) in mammals and teleost fish. Photochem. Photobiol. Sci. 2004, 3:617-627.
8. Foster R.G., Provencio I., Hudson D., Fiske S., De Grip W., Menaker M. Circadian photoreception in the retinally degenerate mouse (rd/rd). J. Comp. Physiol. 1991, 169:39-50.
9. Freedman M.S., Lucas R.J., Soni B., von Schantz M., Muñoz M., David-Gray Z., Foster R. Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science 1999, 284:502-504.
10. Gooley J.J., Lu J., Chou T.C., Scammell T.E., Saper C.B. Melanopsin in cells of origin of the retinohypothalamic tract. Nat. Neurosci. 2001, 4:1165.
11. Haefliger I.O., Fleischhauer J.C., Flammer J. In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?. Eye 2000, 14:464-472.
12. Hankins M.W., Lucas R.J. The primary visual pathway in humans is regulated according to long-term light exposure through the action of a nonclassical photopigment. Curr. Biol. 2002, 12:191-198.
13. Hannibal J., Hindersson P., Knudsen S.M., Georg B., Fahrenkrug J. The photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the retinohypothalamic tract. J. Neurosci. 2002, 22(RC191).
14. Hannibal J., Moller M., Ottersen O.P., Fahrenkrug J. PACAP and glutamate are co-stored in the retinohypothalamic tract. J. Comp. Neurol. 2000, 418:147-155.
15. Hattar S., Liao H.W., Takao M., Berson D.M., Yau K.W. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 2002, 295:1065-1070.
16. Klein D.C., Moore R.Y. Pineal N-acetyltransferase and hydroxyindole-O-methyltransferase: control by the retinohypothalamic tract and the suprachiasmatic nucleus. Brain Res. 1979, 174:245-262.
17. Klein D.C., Moore R.Y., Reppert S.M. Suprachiasmatic Nucleus: The Mind's Clock 1991, Oxford University Press, New York.
18. Klerman E.B., Shanahan T.L., Brotman D.J., Rimmer D.W., Emens J.S., Rizzo J.F., Czeisler C.A. Photic resetting of the human circadian pacemaker in the absence of conscious vision. J. Biol. Rhythms. 2002, 17:548-555.
19. Larsen P.J., Enquist L.W., Card J.P. Characterization of the multisynaptic neuronal control of the rat pineal gland using viral transneuronal tracing. Eur. J. Neurosci. 1998, 10:128-145.
20. Leger D., Guilleminault C., Defrance R., Domont A., Paillard M. Prevalence of sleep/wake disorders in persons with blindness. Clin. Sci. 1999, 97:193-199.
21. Lewy A.J., Cutler N.L., Sack R.L. The endogenous melatonin profile as a marker for circadian phase position. J. Biol. Rhythms. 1999, 14:227-236.
22. Lewy A.J., Wehr T.A., Goodwin F.K., Newsome D.A., Markey S.P. Light suppresses melatonin secretion in humans. Science 1980, 210:1267-1269.
23. Li R.S., Chen B.Y., Tay D.K., Chan H.H., Pu M.L., So K.F. Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model. Invest. Ophthalmol. Vis. Sci. 2006, 47:2951-2958.
24. Lockley S.W., Skene D.J., Arendt J., Tabandeh H., Bird A.C., Defrance R. Relationship between melatonin rhythms and visual loss in the blind. J. Clin. Endocrinol. Metab. 1997, 82:3763-3770.
25. Lucas R.J., Freedman M.S., Muñoz M., Garcia-Fernández J.M., Foster R.G. Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. Science 1999, 16:505-507.
26. Lucas R.J., Hattar S., Takao M., Berson D.M., Foster R.G., Yau K.W. Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice. Science 2003, 299:245-247.
27. McIntyre I.M., Norman T.R., Burrows G.D., Armstrong S.M. Human melatonin suppression by light is intensity dependent. J. Pineal Res. 1989, 6:149-156.
28. Moore R.Y., Lenn N.J. A retinohypothalamic projection in the rat. J. Comp. Neurol. 1972, 146:1-14.
29. Nork T.M., Ver Hoeve J.N., Poulsen G.L. Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch. Ophthalmol. 2000, 118:235-245.
30. Panda S., Jonas J.B. Decreased photoreceptor count in human eyes with secondary angular-closure glaucoma. Invest. Ophthalmol. Vis. Sci. 1992, 33:2532-2536.
31. Panda S., Sato T.K., Castrucci A.M., Rollag M.D., DeGrip W.J., Hogenesch J.B., Provencio I., Kay S.A. Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science 2002, 298:2213-2216.
32. Provencio I., Rodriguez I.R., Jiang G., Hayes W.P., Moreira E.F., Rollag M.D. A novel human opsin in the inner retina. J. Neurosci. 2000, 20:600-605.
33. Provencio I., Wong S., Lederman A.B., Argamaso S.M., Foster R.G. Visual and circadian responses to light in aged retinally degenerate mice. Vision Res. 1994, 34:1799-1806.
34. Reppert S.M. Circadian rhythms: basic aspects and pediatric implications. Current Concepts in Pediatric Endocrinology 1987, 91-125. Elsevier, New York. D.M. Styne, C.G.D. Brook (Eds.).
35. Robinson G.A., Madison R.D. Axotomized mouse retinal ganglion cells containing melanopsin show enhanced survival, but not enhanced regrowth into a peripheral nerve graft. Vision Res. 2004, 44:2667-2674.
36. Ruberg F.L., Skene D.J., Hanifin J.P., Rollaq M.D., English J. Melatonin regulation in humans with color vision deficiencies. J. Clin. Endocrinol. Metab. 1996, 81:2980-2985.
37. Ruby N.F., Brennan T.J., Xie X., Cao V., Franken P., Heller H.C., O'Hara B.F. Role of melanopsin in circadian responses to light. Science 2002, 298:2211-2213.
38. Sack R.L., Lewy A.J., Blood M.L., Keith L.D., Nakagawa H. Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J. Clin. Endocrinol. Metab. 1992, 75:127-134.
39. Tabandeh H., Lockley S.W., Buttery R., Skene D.J., Defrance R., Arendt J., Bird A.C. Disturbance of sleep in blindness. Am. J. Ophthalmol. 1998, 126:707-712.
40. Vaegan E., Graham S.L., Goldberg I., Buckland L., Hollows F.C. Flash and pattern electroretinogram changes in optic atrophy and glaucoma. Exp. Eye Res. 1995, 60:697-706.
41. Voultsios A., Kennaway D.J., Dawson D. Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. J. Biol. Rhythms. 1997, 12:457-466.
42. Wang H.Z., Lu Q.J., Wang N.L., Liu H., Zhang L., Zhan G.L. Loss of melanopsin-containing retinal ganglion cells in a rat glaucoma model. Chin. Med. J. 2008, 121:1015-1019.
43. Webb S.M., Puig-Domingo M. Role of melatonin in health and disease. Clin. Endocrinol. 1995, 42:221-234.